You are not logged in.

A phase I/II study of LDE225, a smoothened (Smo) antagonist, in pediatric patients with recurrent medulloblastoma (MB) or other solid tumors

Geoerger, Birgit, Aerts, Isabelle, Casanova, Michela, Chisholm, Julia C., Hargrave, Darren R., Leary, Sarah, Ashley, David M., Bouffet, Eric, Macdonald, Tobey, Hurh, Eunju, Dey, Jyotirmoy, Kalambakas, Stacey, Amakye, Dereck Dokyi and Kieran, Mark W. 2012, A phase I/II study of LDE225, a smoothened (Smo) antagonist, in pediatric patients with recurrent medulloblastoma (MB) or other solid tumors, in ASCO 2012: Collaborating to conquer cancer : Proceedings of the American Society of Clinical Oncology 2012 meeting, American Society of Clinical Oncology, Alexandria, Va., pp. 1-1.

Attached Files
Name Description MIMEType Size Downloads

Title A phase I/II study of LDE225, a smoothened (Smo) antagonist, in pediatric patients with recurrent medulloblastoma (MB) or other solid tumors
Author(s) Geoerger, Birgit
Aerts, Isabelle
Casanova, Michela
Chisholm, Julia C.
Hargrave, Darren R.
Leary, Sarah
Ashley, David M.
Bouffet, Eric
Macdonald, Tobey
Hurh, Eunju
Dey, Jyotirmoy
Kalambakas, Stacey
Amakye, Dereck Dokyi
Kieran, Mark W.
Conference name American Society of Clinical Oncology.Meeting (2012 : Chicago, Ill.)
Conference location Chicago, Ill.
Conference dates 1-5 Jun. 2012
Title of proceedings ASCO 2012: Collaborating to conquer cancer : Proceedings of the American Society of Clinical Oncology 2012 meeting
Editor(s) [Unknown]
Publication date 2012
Conference series American Society of Clinical Oncology Meeting
Start page 1
End page 1
Total pages 1
Publisher American Society of Clinical Oncology
Place of publication Alexandria, Va.
Keyword(s) children
cancer
recurrent medulloblastoma
oncology
LDE225
Language eng
Field of Research 119999 Medical and Health Sciences not elsewhere classified
Socio Economic Objective 970111 Expanding Knowledge in the Medical and Health Sciences
HERDC Research category E2.1 Full written paper - non-refereed / Abstract reviewed
Copyright notice ©2012, American Society of Clinical Oncology
Persistent URL http://hdl.handle.net/10536/DRO/DU:30055016

Document type: Conference Paper
Collection: School of Medicine
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 3 times in TR Web of Science
Scopus Citation Count Cited 0 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 111 Abstract Views, 2 File Downloads  -  Detailed Statistics
Created: Thu, 22 Aug 2013, 11:33:31 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.